Histopathology and In Situ Hybridisation
Facilitating all aspects of histopathology including processing, embedding, sectioning, histochemical staining, tissue microarray building, immunohistochemistry, in situ hybridisation, whole slide scanning, and image analysis.
The ‘Histocore’ provides routine histological processing, tissue sectioning, immunohistochemistry (IHC), in situ hybridisation (ISH), and whole slide scanning services to Institute researchers (and external users where capacity allows). Histological services include the capability to process tissue samples and cell lines into frozen, paraffin or vibratome formats for sectioning and staining. The Core constructs tissue microarrays (TMAs) for users and trains in the use of Laser Capture Microdissection (LCM). We also offer image analysis services, so can offer a complete end-to-end service if required.
Jo Arnold
Core Facility Manager
Services
Team members
-
Julia Jones
Scientific Manager
-
Jodi Miller
Principal Scientific Associate
-
Jo Heffer
Senior Scientific Associate
-
Cara Brodie
Senior Scientific Associate
-
Elsa Santos
Scientific Associate
-
Rita Carreira
Scientific Associate
-
Caroline Powell
Research Assistant
-
Julia Ponte
Research Assistant
-
Sophie Dickinson
Research Assistant
Related News
See all news-
Identifying tumour characteristics to predict immunotherapy response
6th September 2023
Tumour characteristics could be used to predict whether patients with an aggressive subtype of breast cancer are able to respond to immunotherapy.
Find out more -
Breakthrough in understanding of how cancer spreads could lead to better treatments
29th September 2022
The Gilbertson Group have discovered that cancer cells ‘hijack’ a process used by healthy cells to spread around the body.
Find out more -
Ancient signalling pathway could provide treatment hope for Inflammatory Bowel Disease
22nd July 2022
An ancient signalling pathway, known as the Hedgehog pathway, plays a vital role in inflammatory bowel disease (IBD) and may be a druggable target for treatment, according to new research from the de la Roche group.
Find out more